Works matching IS 07248741 AND DT 2022 AND VI 39 AND IP 5
Results: 18
Transcriptome Profiling Analysis Identifies LCP1 as a Contributor for Chidamide Resistance in Gastric Cancer.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 5, p. 867, doi. 10.1007/s11095-022-03291-1
- By:
- Publication type:
- Article
Development and Use of an Ex-Vivo In-Vivo Correlation to Predict Antiepileptic Drug Clearance in Patients Undergoing Continuous Renal Replacement Therapy.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 5, p. 827, doi. 10.1007/s11095-022-03287-x
- By:
- Publication type:
- Article
Understanding Formulation and Temperature Effects on Dermal Transport Kinetics by IVPT and Multiphysics Simulation.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 5, p. 893, doi. 10.1007/s11095-022-03283-1
- By:
- Publication type:
- Article
Liposomal Formulation for Oral Delivery of Cyclosporine A: Usefulness as a Semisolid-Dispersion System.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 5, p. 977, doi. 10.1007/s11095-022-03276-0
- By:
- Publication type:
- Article
Impact of Select Geometric and Operational Parameters on Hydrodynamics in Dissolution Apparatus 2 (Paddle Apparatus): A Design of Experiments Analysis Based on Computational Fluid Dynamics Simulations.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 5, p. 919, doi. 10.1007/s11095-022-03272-4
- By:
- Publication type:
- Article
Seeing Is Believing: Time-Lapse Macro-Imaging of Morphological Changes of Solid Dosages as a Teaching and Research Tool.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 5, p. 1019, doi. 10.1007/s11095-022-03271-5
- By:
- Publication type:
- Article
Modeling Drug Dissolution in 3-Dimensional Space.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 5, p. 907, doi. 10.1007/s11095-022-03270-6
- By:
- Publication type:
- Article
Use of Flory–Huggins Interaction Parameter and Contact Angle Values to Predict the Suitability of the Drug-Polymer System for the Production and Stability of Nanosuspensions.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 5, p. 1001, doi. 10.1007/s11095-022-03269-z
- By:
- Publication type:
- Article
In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT<sub>1A</sub> Receptor Agonist for the Treatment of Schizophrenia.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 5, p. 837, doi. 10.1007/s11095-022-03267-1
- By:
- Publication type:
- Article
Role of Tissue Hydraulic Permeability in Convection-Enhanced Delivery of Nanoparticle-Encapsulated Chemotherapy Drugs to Brain Tumour.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 5, p. 877, doi. 10.1007/s11095-022-03261-7
- By:
- Publication type:
- Article
Correction to: Control of Drug-Excipient Particle Attributes with Droplet Microfluidic-based Extractive Solidification Enables Improved Powder Rheology.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction to: Preparation and Preclinical Evaluation of Inhalable Particles Containing Rapamycin and Anti-Tuberculosis Agents for Induction of Autophagy.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
The Relationship between the Drug Delivery Properties of a Formulation of Teriparatide Microneedles and the Pharmacokinetic Evaluation of Teriparatide Administration in Rats.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 5, p. 989, doi. 10.1007/s11095-022-03254-6
- By:
- Publication type:
- Article
A Novel Faster-Acting, Dry Powder-Based, Naloxone Intranasal Formulation for Opioid Overdose.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 5, p. 963, doi. 10.1007/s11095-022-03247-5
- By:
- Publication type:
- Article
Application of Confocal Raman Microscopy for the Characterization of Topical Semisolid Formulations and their Penetration into Human Skin Ex Vivo.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 5, p. 935, doi. 10.1007/s11095-022-03245-7
- By:
- Publication type:
- Article
Combination of co-crystal and nanocrystal techniques to improve the solubility and dissolution rate of poorly soluble drugs.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 5, p. 949, doi. 10.1007/s11095-022-03243-9
- By:
- Publication type:
- Article
A Charge Variant of Bevacizumab Offers Enhanced FcRn-Dependent Pharmacokinetic Half-Life and Efficacy.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 5, p. 851, doi. 10.1007/s11095-022-03236-8
- By:
- Publication type:
- Article
Correction to: The Influence of Stabilized Deconjugated Ursodeoxycholic Acid on Polymer-Hydrogel System of Transplantable NIT-1 Cells.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice